Flavin-containing monooxygenase
(Redirected from Flavin-containing monooxygenase system)
Flavin-containing monooxygenase (FMO) is a class of important enzymes involved in the metabolism of a wide variety of xenobiotics, such as drugs, pesticides, and dietary compounds, as well as endogenous substances. These enzymes catalyze the oxygenation of nucleophilic nitrogen, sulfur, selenium, and phosphorus atoms in organic compounds. The FMO family is distinguished by its use of a flavin adenine dinucleotide (FAD) cofactor to facilitate the transfer of oxygen from molecular oxygen (O2) to the substrate.
Function[edit | edit source]
The primary function of flavin-containing monooxygenases is to catalyze the oxidation of soft nucleophiles by inserting one atom of oxygen into the substrate while reducing the other oxygen atom to water. This process is crucial for the detoxification and elimination of potentially harmful substances. FMOs are found in the liver and are heavily involved in drug metabolism, playing a significant role in the pharmacokinetics of many medications.
Structure[edit | edit source]
FMO enzymes are membrane-bound proteins located in the endoplasmic reticulum. They are composed of a single polypeptide chain that binds to one molecule of FAD. The structure of FMOs is critical for their function, as the active site where the substrate binds is located near the FAD cofactor, facilitating efficient electron transfer and catalysis.
Types[edit | edit source]
There are several types of FMOs identified in humans, numbered FMO1 through FMO6. Each type has a specific tissue distribution and substrate specificity, which can vary significantly among different species. For example, FMO3 is the most abundant in the human liver and is responsible for the metabolism of a wide range of drugs and xenobiotics.
Clinical Significance[edit | edit source]
Alterations in FMO activity can have significant clinical implications. Genetic polymorphisms in FMO genes can lead to variations in enzyme activity among individuals, affecting drug metabolism and potentially leading to adverse drug reactions. Furthermore, certain diseases can alter FMO expression and activity, impacting drug efficacy and toxicity.
Research[edit | edit source]
Research on flavin-containing monooxygenases continues to uncover their complex roles in metabolism and their implications for pharmacology and toxicology. Understanding the specific activities and regulation of different FMOs is crucial for predicting drug interactions and developing safer and more effective therapeutic agents.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD